Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
Exocell/hCollagen IV/1015 Strip Plate188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Exocell/hCollagen IV/1015 Strip Plate

hCollagenIV


Manufacturer/Trade:Exocell/CollagenIVH
CatalogueNumbers:1015StripPlate
Methodology:CompetitiveELISA
Summaryofprocedure:

CollagenIVHisanindirectcompetitiveELISAdesignedtomeasuretypeIVcollageninBIOLOGicalandtissueculturespecimensofhumanorigin.Theassaymaybecompletedina“normalsensitivity”mode,withausefulassayrangeof0.156-10ugcollagenIV/mL.Aslightlydifferentprocedure,the“enhancedsensitivity”modetypicallyyieldsausefulassayrangeof0.02-2.5ug/mL,andissensitiveenoughtodetectcollagenIVinurinespecimens.

Tocompletetheassay,sampleandgoatanti-collagenIVantibodyareaddedtohumancollagenIVcoatedwells.TheantibodyinteractsandbindswiththecollagenIVimmobilizedtothestationaryphaseorwiththeantigeninthefluidphase,hencethenotionofcompetitivebinding.Afterasuitableincubationperiod,theplatesarewashed,andarabbitanti-goat-HRPconjugateisusedtodetectboundantibody.Afterwashing,onlytheantibody-conjugateboundtothestationaryphaseremainsinthewell,andthisisdetectedusingachromogenicreaction.ColorintensityisinverselyproportionaltothelogarithmofcollagenIVinthefluidphase.Theassaymaybecompletedinlessthan3hours.

The“enhancedsensitivity”modeiscompletedbyplacingthesamplesandanti-collagenIVantibodyintotubesandincubating2-24hours.Here,theantibodycanonlyreactwiththecollagenIVofthefluidphase.Subsequently,aliquotsofthemixtureareaddedtotheplatewhereremainingfreeantibodycanreactwiththeantigenofthestationaryphase.Theboundantibodyisdetectedasdescribedabove.

SpecimenRequired:50-100uLCellCultureExtract,Urine
AssayRange:

NormalSensitivity:0.156-10ug/mL

EnhancedSensitivity:0.02-2.5ug/mL

Precision:IntraassayandinterassayprecisionforsampleswithintheusefulrangeoftheassayhaveaC.V.<10%ofthemean.



©2012ExocellInc.